GS-443902

Modify Date: 2024-01-12 16:09:50

GS-443902 Structure
GS-443902 structure
Common Name GS-443902
CAS Number 1355149-45-9 Molecular Weight 531.202
Density 2.4±0.1 g/cm3 Boiling Point N/A
Molecular Formula C12H16N5O13P3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of GS-443902


GS-443902 (Remdesivir metabolite) is a potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 5.6 µM, 1.1 µM, 5 µM for TP RdRp, RSV RdRp and HCV RdRp, respectively. GS-443902 is the active triphosphate metabolite of Remdesivir[1][2].

 Names

Name GS 441524 triphosphate
Synonym More Synonyms

 GS-443902 Biological Activity

Description GS-443902 (Remdesivir metabolite) is a potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 5.6 µM, 1.1 µM, 5 µM for TP RdRp, RSV RdRp and HCV RdRp, respectively. GS-443902 is the active triphosphate metabolite of Remdesivir[1][2].
Related Catalog
Target

IC50: 5.6 µM (TP RdRp), 1.1 µM (RSV RdRp) and 5 µM (HCV RdRp)[1][2]

In Vitro GS-443902 (compound 8a), a triphosphates (TP) derivative, is a potent inhibitory activity against the enzyme TP RdRp (IC50=5.6 µM)[1]. In a continuous 72 h incubation of 1 µM GS-5734, the GS-443902 (compound 4tp) level is measured at 2, 24, 48 and 72 h, and reaches a Cmax of 300, 110, and 90 pmol/million cells in macrophages, HMVEC, and HeLa cells lines respectively[2]. GS-443902 (NTP; 0.01, 0.1, 1, 10, 100 μM) inhibits RSV RdRp-catalysed RNA synthesis by incorporating into the nascent viral RNA transcript and causing its premature termination. GS-5734 selectively inhibits EBOV replication by targeting its RdRp and inhibiting viral RNA synthesis following efficient intracellular conversion to GS-443902[3].
In Vivo GS-5734 (10 mg kg; i.v.) rapidly distributes into peripheral blood mononuclear cells (PBMCs), and efficient conversion to GS-443902 (NTP) is apparent within 2 h of dose administration in rhesus monkeys. In PBMCs, GS-443902 represents the predominant metabolite and is persistent with a t1/2 of 14 h and levels required for >50% virus inhibition for 24 hours[3].
References

[1]. Siegel D, et al. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses. Med Chem. 2017 Mar 9;60(5):1648-1661.

[2]. Cho A, et al. Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7.

[3]. Warren TK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016 Mar 17;531(7594):381-5.

 Chemical & Physical Properties

Density 2.4±0.1 g/cm3
Molecular Formula C12H16N5O13P3
Molecular Weight 531.202
Exact Mass 530.995728
LogP -5.92
Index of Refraction 1.841
Storage condition -20°C

 Synonyms

((2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate
GS-441524
Top Suppliers:I want be here


Get all suppliers and price by the below link:

GS-443902 suppliers


Price: ¥16500/5 mg

Reference only. check more GS-443902 price